Merck IMPROVEs-IT Causing These Biotechs' Stock Prices to Improve Too

November 18, 2014 9:37 PM

13 0

Pop quiz: Which one of these drug companies released major positive clinical trial data yesterday?

By investors' reactions, you'd think it was Esperion Therapeutics or maybe Regeneron Pharmaceuticals, but instead it was Merck that finally released data from its IMPROVE-IT clinical trial comparing Merck's Vytorin to Zocor. Vytorin is a combination of Zetia and Zocor, both Merck's, so you can also ...

Read more

To category page